Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2000, p. 6008-6018, Vol. 20, No. 16
Department of Molecular Genetics, University
of Illinois at Chicago, Chicago, Illinois 60607
Received 25 February 2000/Returned for modification 10 April
2000/Accepted 17 May 2000
Analysis of amino-terminus mutants of c-Myc has allowed a
systematic study of the interrelationship between Myc's ability to
regulate transcription and its apoptotic, proliferative, and transforming functions. First, we have found that c-Myc-accelerated apoptosis does not directly correlate with its ability to transactivate transcription using the endogenous ornithine decarboxylase (ODC) gene
as readout for transactivation. Furthermore, deletion of the conserved
c-Myc box I domain implicated in transactivation does not inhibit
apoptosis. Second, the ability of c-Myc to repress transcription, using
the gadd45 gene as a readout, correlates with its ability to accelerate
apoptosis. A conserved region of c-Myc implicated in mediating
transrepression is absolutely required for c-Myc-accelerated apoptosis.
Third, a lymphoma-derived Thr58Ala mutation diminishes
c-Myc-accelerated apoptosis through a decreased ability to induce the
release of cytochrome c from mitochondria. This mutation in
a potential phosphorylation site does not affect cell cycle
progression, providing genetic evidence that induction of cell cycle
progression and acceleration of apoptosis are two separable functions
of c-Myc. Finally, we show that the increased ability of Thr58Ala
mutant to elicit cellular transformation correlates with its diminished
ability to accelerate apoptosis. Bcl-2 overexpression blocked and the
lymphoma-associated Thr58Ala mutation decreased c-Myc-accelerated
apoptosis, and both led to a significant increase in the ability of
Rat1a cells to form colonies in soft agar. This enhanced transformation
was greater in soft agar containing a low concentration of serum,
suggesting that protection from apoptosis is a mechanism contributing
to the increased ability of these cells to proliferate in suspension.
Thus, we show here for the first time that, in addition to mutations in
complementary antiapoptotic genes, c-Myc itself can acquire mutations
that potentiate neoplastic transformation by affecting apoptosis
independently of cell cycle progression.
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Induction of Cell Cycle Progression and
Acceleration of Apoptosis Are Two Separable Functions of c-Myc:
Transrepression Correlates with Acceleration of Apoptosis


*
Corresponding author. Mailing address: Department of
Molecular Genetics, M/C 669, University of Illinois at Chicago, 900 South Ashland Ave., Chicago, IL 60607. Phone: (312) 355-1684. Fax:
(312) 355-2032. E-mail: nhay{at}uic.edu.
Present address: Department of Medicine, University of Chicago,
Chicago, IL 60637.
Present address: Department of Medicine, Brigham and Women's
Hospital, Boston, MA 02115.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|